ArticlePloS one2012

Skin-targeted inhibition of PPAR β/δ by selective antagonists to treat PPAR β/δ-mediated psoriasis-like skin disease in vivo.

Katrin Hack et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.